World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
52
Citations
9571
World Ranking
16696
National Ranking
6898

Paul K. Wallace publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Paul K. Wallace sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 328 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Paul K. Wallace D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Paul K. Wallace sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 52 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Paul K. Wallace is affiliated with the Roswell Park Cancer Institute in the United States. Their research spans multiple areas within medicine, particularly focusing on hematology, oncology, and immunology. The scientist has published extensively on topics including multiple myeloma research and treatments, cancer immunotherapy and biomarkers, immune cell function and interaction, single-cell and spatial transcriptomics, acute myeloid leukemia research, cancer genomics and diagnostics, and hematopoietic stem cell transplantation.

Paul K. Wallace has contributed to a range of recent scholarly articles. Notable papers include:

  • Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity, 2020, Clinical Cancer Research
  • Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma, 2022, Nature Communications
  • CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab, 2020, Cytometry Part B Clinical Cytometry
  • Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT), 2022, Blood Cancer Journal
  • Tumor and immune remodeling following radiotherapy in human renal cell carcinoma, 2023, Journal for ImmunoTherapy of Cancer

The scientist frequently collaborates with several co-authors, including Joseph D. Tario, Philip L. McCarthy, Theresa Hahn, Jens Hillengaß, and Kah Teong Soh. These partnerships appear repeatedly in their body of work, indicating ongoing collaborative research efforts.

Paul K. Wallace's research has been published predominantly in specific venues. These include:

  • Cytometry Part B Clinical Cytometry
  • Journal of Clinical Oncology
  • Blood
  • Transplantation and Cellular Therapy
  • Journal for ImmunoTherapy of Cancer

The scientist's main fields of study are Medicine, with a significant number of publications in Biochemistry, Genetics, and Molecular Biology. Subfields include Hematology, Oncology, Immunology, Molecular Biology, and Genetics, reflecting a multidisciplinary approach to complex medical and biological questions.

Best Publications

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study.

    Simon Wessely;Trudie Chalder;S Hirsch;P Wallace

  • Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study

    Asher Chanan-Khan;Kena C. Miller;Laurie Musial;David Lawrence

  • Human monocytes express CD163, which is upregulated by IL-10 and identical to p155.

    Timothy H Sulahian;Petra Högger;Andrea E Wahner;Kathleen Wardwell

  • Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo

    Nishitha Reddy;Francisco J. Hernandez-Ilizaliturri;George Deeb;Mark Roth

  • Rapid-Learning System for Cancer Care

    Amy P. Abernethy;Lynn M. Etheredge;Patricia A. Ganz;Paul Wallace

  • Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting.

    Simon Wessely;Trudie Chalder;Steven Hirsch;Paul Wallace

  • 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.

    Brent L. Wood;Maria Arroz;David Barnett;Joseph DiGiuseppe

  • Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163.

    Katharine A. Hintz;Athos J. Rassias;Kathleen Wardwell;Marcia L. Moss

  • NADPH oxidase limits innate immune responses in the lungs in mice.

    Brahm H. Segal;Brahm H. Segal;Wei Han;Jennifer J. Bushey;Myungsoo Joo

  • Understanding the normalization of telemedicine services through qualitative evaluation

    Carl R. May;Robert Harrison;Tracy Finch;Anne MacFarlane

  • Joint teleconsultations (virtual outreach) versus standard outpatient appointments for patients referred by their general practitioner for a specialist opinion: a randomised trial.

    P Wallace;A Haines;R Harrison;J Barbour

  • Tracking antigen‐driven responses by flow cytometry: Monitoring proliferation by dye dilution

    Paul K. Wallace;Joseph D. Tario;Jan L. Fisher;Stephen S. Wallace

  • Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer

    Feng Qian;Jeannine Villella;Paul K. Wallace;Paulette Mhawech-Fauceglia

  • Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules

    Venky Ramakrishna;John F. Treml;Laura Vitale;John E. Connolly

  • A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens

    Alice L Givan;Jan L Fisher;Mary Waugh;Marc S Ernstoff

  • Increased potency of Fc-receptor-targeted antigens

    P. M. Guyre;Robert F. Graziano;Joel Goldstein;Paul K. Wallace

  • Experiences of refugees and asylum seekers in general practice: a qualitative study

    Ravi Bhatia;Paul Wallace

  • Use of a questionnaire in general practice to increase the recognition of patients with excessive alcohol consumption.

    P Wallace;A Haines

  • Central Role of IL-6 Receptor Signal-Transducing Chain gp130 in Activation of L-Selectin Adhesion by Fever-Range Thermal Stress

    Qing Chen;Wan Chao Wang;Robert Bruce;Hong Li

Frequent Co-Authors

George Chen
George Chen University of Southampton
Marc S. Ernstoff
Marc S. Ernstoff Roswell Park Cancer Institute
Paul M. Guyre
Paul M. Guyre Dartmouth College
Michael W. Fanger
Michael W. Fanger Dartmouth College
Tibor Keler
Tibor Keler Bristol-Myers Squibb (United States)
Myron S. Czuczman
Myron S. Czuczman Citius Pharmaceuticals, Inc.
Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Kelvin P. Lee
Kelvin P. Lee Roswell Park Comprehensive Cancer Center
Diane R. Gold
Diane R. Gold Harvard University
James E. Gern
James E. Gern University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in Biology and Biochemistry, several related online degrees and career pathways can complement your qualifications. Many students pursue healthcare management, laboratory management, or specialized roles in data analysis and medical coding.

Earning an MBA can be a great way to transition into healthcare leadership roles. To make an informed decision, it's important to consider healthcare mba cost as tuition rates can vary widely depending on the program and school.

Another in-demand pathway is medical coding and billing. Certifications matter in this field, with options such as CPC and CCS available. Understanding the ccs vs cpc certifications will help you determine which credential aligns best with your skills and career goals.

Career prospects in medical coding are strong, with competitive medical coding jobs salary trends and opportunities for advancement. Additionally, the job outlook for medical billing and coding remains positive, making it a viable pathway for those interested in healthcare without direct patient care.

Best Scientists Citing Paul K. Wallace

Trending Scientists

Recently Published Articles